Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
10 February 2021 - 10:08PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of
Foreign Private Issuer
Pursuant to Rule 13a-16 or
15d-16
under the Securities Exchange Act of 1934
For February 10, 2021
Commission File Number 001-39670
PURETECH HEALTH PLC
6
Tide Street, Suite 400
Boston, Massachusetts 02210
Attention: Chief Executive Officer
(617) 482-2333
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On February 10, 2021, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) issued a press release announcing its sale of 1,000,000 shares of common
stock of its Founded Entity, Karuna Therapeutics, Inc. The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.
Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
PURETECH HEALTH PLC
|
|
|
|
|
Date: February 10, 2021
|
|
|
|
By:
|
|
/s/ Daphne Zohar
|
|
|
|
|
|
|
Name: Daphne Zohar
|
|
|
|
|
|
|
Title: Chief Executive Officer
|
PureTech Health (NASDAQ:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
PureTech Health (NASDAQ:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024